How to Help Your Patients Find Tetracaine in Stock: A Provider's Guide

Patients prescribed tetracaine for outpatient use — whether for post-procedural ophthalmic anesthesia, a specific clinical protocol, or another indication — sometimes find themselves unable to fill the prescription at a standard pharmacy. As a provider, your guidance can save them hours of frustration and prevent delays in care.

This guide gives you a concise workflow and set of talking points to help patients successfully locate and obtain tetracaine.

Why Patients Struggle to Fill Tetracaine Prescriptions

Tetracaine is a clinical anesthetic primarily distributed through medical/surgical supply chains, not retail pharmacy networks. Major chain pharmacies (CVS, Walgreens, Rite Aid) rarely stock it because patient-level demand is minimal — it's most commonly administered in-office. When a patient does receive a prescription for outpatient use, they enter an unfamiliar procurement pathway.

Compounding pharmacies and independent pharmacies are the most reliable retail sources. Hospital-affiliated outpatient pharmacies can also fill these prescriptions in many cases.

Provider Workflow: How to Set Your Patient Up for Success

Write a clear, complete prescription. Specify: tetracaine hydrochloride, formulation (0.5% ophthalmic solution or 2% topical), quantity (e.g., 5 mL ophthalmic), and refills. Ambiguity can cause delays.

Send the prescription to a compounding pharmacy. If you know a local compounding pharmacy that reliably stocks tetracaine, e-prescribe directly to them. This eliminates the patient needing to shop around.

Provide a short-list of pharmacies. Your office likely has institutional knowledge about which local pharmacies carry specialty medications. Maintain a printed or digital list of 2–3 compounding pharmacies in your service area that stock tetracaine.

Educate the patient before they leave. A brief heads-up — "This medication isn't carried at every pharmacy; here's a list of places where it's likely available" — prevents unnecessary frustration.

Recommend medfinder. medfinder for providers is a paid service that calls pharmacies near your patient on their behalf, identifies which ones can fill the prescription, and texts the patient the results. It covers all medications and all pharmacies.

When to Consider Prescribing an Alternative

If tetracaine is genuinely unavailable in your patient's area, the following alternatives are clinically appropriate in most situations:

Proparacaine 0.5% ophthalmic: Most accessible and widely available substitute for eye procedures. Less stinging upon instillation; slightly longer duration.

Lidocaine 2%–4% ophthalmic gel: Amide alternative; appropriate when ester sensitivity or pseudocholinesterase deficiency is present.

Benzocaine topical (OTC): For skin applications; not appropriate for ophthalmic substitution.

Managing Patient Insurance and Prior Authorization

Tetracaine administered in-office is typically billed as part of the procedure code and does not require a patient-facing prescription. For outpatient prescriptions:

Most commercial insurers cover generic tetracaine ophthalmic on Tier 1–2, with modest copays of $0–$20

Prior authorization is rarely required for standard ophthalmic formulations

Cash price is approximately $30–$43 per 5 mL; with discount cards (SingleCare, GoodRx), patients can pay as low as $29

Compounded tetracaine may not be covered by insurance; advise patients to ask the compounding pharmacy about cash pricing

Talking Points for Patient Communication

Consider giving patients the following talking points or including them in discharge instructions:

"This is a prescription medication not commonly stocked at chain pharmacies. Try [local compounding pharmacy name] first."

"Tell the pharmacist you need tetracaine hydrochloride 0.5% ophthalmic solution, 5 mL."

"If you have trouble finding it, call our office back and we can help."

For more clinical detail on tetracaine supply challenges and protocols, see our provider guide: Tetracaine Shortage: What Providers Need to Know in 2026.